Stock Code
603707.SH
Global Market Commercialization Platform
Annual sales growth of over 400% from 2016 to 2019
Detached International Sales Team
The US company Meitheal Pharmaceuticals was founded in December, 2016 and was acquired by Kingfriend in 2019 and formed scale sales in 2020.
Meitheal Today
-
Chicago-based injectable generic drug distribution company
-
Experienced leadership,
With nearly 150 years of experience in the U.S. generics industry
-
Approximately 70 employees,
involved in clinical, registration, marketing and sales.
-
Stable equity structure and positive growth projections
-
Grouping a hospital sales team in 2019
-
Diversified product range:
Products are involved in many different clinical departments
-
With our Partner Nanjing King-Friend(NKF), who are approved by FDA, we are committed to producing high quality products.
-
Seeking further opportunities in the biologics and biosimilars market
Talk to our researchers about your project
Click to enter
Stock price
13.240
-0.06
©2024 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd苏ICP备13012010号
